CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 28,502 shares at an average $6.23 ($177,509)
- 4 Grant or award EVP & Chief Medical Officer acquired 65,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Scientific Officer acquired 60,000 shares (grant or award)
- 4 Open-market sale EVP, Chief Dev. Officer sold 1,663 shares at $10.24 ($17,025)
- 4 Open-market sale EVP, CFO & Treasurer sold 2,398 shares at $10.24 ($24,550)
- 4 Open-market sale Chief Scientific Officer sold 12,452 shares at $10.24 ($127,477)
- 4 Open-market sale Director sold 12,452 shares at $10.24 ($127,477)
- 4 Grant or award SVP, Chief Business Officer acquired 47,250 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 84,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 288,750 shares (grant or award)
- 4 Grant or award SVP, General Counsel&Secretary acquired 63,000 shares (grant or award)
- 4 Open-market sale EVP, Chief Medical Officer sold 1,306 shares at $12.12 ($15,833)
- 4 Open-market sale EVP, Chief Dev. Officer sold 2,929 shares at $12.12 ($35,509)
Page 10 of 31 · 601 filings